These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17548622)

  • 1. IgG opsonization of HIV impedes provirus formation in and infection of dendritic cells and subsequent long-term transfer to T cells.
    Wilflingseder D; Banki Z; Garcia E; Pruenster M; Pfister G; Muellauer B; Nikolic DS; Gassner C; Ammann CG; Dierich MP; Piguet V; Stoiber H
    J Immunol; 2007 Jun; 178(12):7840-8. PubMed ID: 17548622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-type lectin-independent interaction of complement opsonized HIV with monocyte-derived dendritic cells.
    Pruenster M; Wilflingseder D; Bánki Z; Ammann CG; Muellauer B; Meyer M; Speth C; Dierich MP; Stoiber H
    Eur J Immunol; 2005 Sep; 35(9):2691-8. PubMed ID: 16094691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies attenuate the capacity of dendritic cells to stimulate HIV-specific cytotoxic T lymphocytes.
    Posch W; Cardinaud S; Hamimi C; Fletcher A; Mühlbacher A; Loacker K; Eichberger P; Dierich MP; Pancino G; Lass-Flörl C; Moris A; Saez-Cirion A; Wilflingseder D
    J Allergy Clin Immunol; 2012 Dec; 130(6):1368-74.e2. PubMed ID: 23063584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fcγ Receptor Type I (CD64)-Mediated Impairment of the Capacity of Dendritic Cells to Activate Specific CD8 T Cells by IgG-opsonized Friend Virus.
    Bánki Z; Werner R; Riepler L; Rössler A; Müllauer B; Hegen V; Bayer W; Verbeek JS; Dittmer U; Stoiber H
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30744065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement-Opsonized HIV-1 Alters Cross Talk Between Dendritic Cells and Natural Killer (NK) Cells to Inhibit NK Killing and to Upregulate PD-1, CXCR3, and CCR4 on T Cells.
    Ellegård R; Khalid M; Svanberg C; Holgersson H; Thorén Y; Wittgren MK; Hinkula J; Nyström S; Shankar EM; Larsson M
    Front Immunol; 2018; 9():899. PubMed ID: 29760706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsonization of HIV with complement enhances infection of dendritic cells and viral transfer to CD4 T cells in a CR3 and DC-SIGN-dependent manner.
    Bouhlal H; Chomont N; Réquena M; Nasreddine N; Saidi H; Legoff J; Kazatchkine MD; Bélec L; Hocini H
    J Immunol; 2007 Jan; 178(2):1086-95. PubMed ID: 17202372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement opsonization of HIV-1 results in a different intracellular processing pattern and enhanced MHC class I presentation by dendritic cells.
    Tjomsland V; Ellegård R; Burgener A; Mogk K; Che KF; Westmacott G; Hinkula J; Lifson JD; Larsson M
    Eur J Immunol; 2013 Jun; 43(6):1470-83. PubMed ID: 23526630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired NK Cell Activation and Chemotaxis toward Dendritic Cells Exposed to Complement-Opsonized HIV-1.
    Ellegård R; Crisci E; Andersson J; Shankar EM; Nyström S; Hinkula J; Larsson M
    J Immunol; 2015 Aug; 195(4):1698-704. PubMed ID: 26157174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-Opsonized HIV-1 Overcomes Restriction in Dendritic Cells.
    Posch W; Steger M; Knackmuss U; Blatzer M; Baldauf HM; Doppler W; White TE; Hörtnagl P; Diaz-Griffero F; Lass-Flörl C; Hackl H; Moris A; Keppler OT; Wilflingseder D
    PLoS Pathog; 2015 Jun; 11(6):e1005005. PubMed ID: 26121641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 selectively infects a subset of nonmaturing BDCA1-positive dendritic cells in human blood.
    Granelli-Piperno A; Shimeliovich I; Pack M; Trumpfheller C; Steinman RM
    J Immunol; 2006 Jan; 176(2):991-8. PubMed ID: 16393985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions.
    Tjomsland V; Ellegård R; Kjölhede P; Wodlin NB; Hinkula J; Lifson JD; Larsson M
    Eur J Immunol; 2013 Sep; 43(9):2361-72. PubMed ID: 23686382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell/T cell co-cultures.
    Döpper S; Wilflingseder D; Prodinger WM; Stiegler G; Speth C; Dierich MP; Stoiber H
    Eur J Immunol; 2003 Aug; 33(8):2098-107. PubMed ID: 12884283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and -independent mechanisms.
    McDyer JF; Dybul M; Goletz TJ; Kinter AL; Thomas EK; Berzofsky JA; Fauci AS; Seder RA
    J Immunol; 1999 Mar; 162(6):3711-7. PubMed ID: 10092834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement Opsonization Promotes Herpes Simplex Virus 2 Infection of Human Dendritic Cells.
    Crisci E; Ellegård R; Nyström S; Rondahl E; Serrander L; Bergström T; Sjöwall C; Eriksson K; Larsson M
    J Virol; 2016 May; 90(10):4939-4950. PubMed ID: 26937039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor I-mediated processing of complement fragments on HIV immune complexes targets HIV to CR2-expressing B cells and facilitates B cell-mediated transmission of opsonized HIV to T cells.
    Bánki Z; Wilflingseder D; Ammann CG; Pruenster M; Müllauer B; Holländer K; Meyer M; Sprinzl GM; van Lunzen J; Stellbrink HJ; Dierich MP; Stoiber H
    J Immunol; 2006 Sep; 177(5):3469-76. PubMed ID: 16920989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite effects of IL-10 on the ability of dendritic cells and macrophages to replicate primary CXCR4-dependent HIV-1 strains.
    Ancuta P; Bakri Y; Chomont N; Hocini H; Gabuzda D; Haeffner-Cavaillon N
    J Immunol; 2001 Mar; 166(6):4244-53. PubMed ID: 11238678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired accessory cell function in a human dendritic cell line after human immunodeficiency virus infection.
    Beuria P; Chen H; Timoney M; Sperber K
    Clin Diagn Lab Immunol; 2005 Mar; 12(3):453-64. PubMed ID: 15753259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1
    Bertacchi G; Posch W; Wilflingseder D
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential infection of dendritic cells during human immunodeficiency virus type 1 infection of blood leukocytes.
    Cameron PU; Handley AJ; Baylis DC; Solomon AE; Bernard N; Purcell DF; Lewin SR
    J Virol; 2007 Mar; 81(5):2297-306. PubMed ID: 17166903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infection.
    Frank I; Robbiani M
    J Acquir Immune Defic Syndr; 2011 Mar; 56(3):204-12. PubMed ID: 21084994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.